Abstract
A California team has shown that inhibiting {MAGL} reduces neuroinflammation in a mouse model of Parkinson's disease. The researchers are now investigating the small molecule's effects in other neurodegenerative and neurological diseases, and newco Abide Therapeutics is exercising an option to license the {MAGL} inhibitors.
Cite
CITATION STYLE
APA
Kotz, J. (2011). Dampening neuroinflammation. Science-Business EXchange, 4(45), 1254–1254. https://doi.org/10.1038/scibx.2011.1254
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free